Event Description
Topic
Personalized Healthcare and Cancer Immunotherapy: Past, Present and Future
Presented By
Eric E. Walk, MD, FCAP, chief medical and scientific officer, senior vice president, Medical and Scientific Affairs, Roche Tissue Diagnostics
Target Audience
Attending pathologists from within Drexel University College of Medicine, its affiliated hospitals and private practice pathologists and pathology fellows.
Educational Objective
Physicians will acquire up-to-date knowledge about specific aspects of pathology theory and practice. Physicians will be exposed to information in specialty areas of pathology that are not a routine aspect of their clinical practice but can enhance their clinical practice
Accredidation Statement
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AOA: This program is eligible for 1 credits in Category 2A of the American Osteopathic Association.
Disclosure
Speakers at continuing medical education activities are required to disclose to the audience, any relevant commercial interest (which is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience.
Dr. Eric E. Walk has no commercial relationships to disclose.
The following Planning Committee Members have no commercial relationships to disclose: Drs. C. Hanau, S. Hou, and B. Mapow. |
